Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Desislava Tsoneva"'
Publikováno v:
Molecular Therapy: Oncolytics, Vol 5, Iss C, Pp 41-61 (2017)
Oncolytic vaccinia virus (VACV) therapy is an alternative cancer treatment modality that mediates targeted tumor destruction through a tumor-selective replication and an induction of anti-tumor immunity. We developed a humanized tumor mouse model wit
Externí odkaz:
https://doaj.org/article/edcec4d93cc046278ffd6f5ee17b6bd9
Autor:
Desislava Tsoneva, Jochen Stritzker, Kristina Bedenk, Qian Zhang, Alexa Frentzen, Joseph Cappello, Utz Fischer, Aladar A Szalay
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0137573 (2015)
Blood tests are necessary, easy-to-perform and low-cost alternatives for monitoring of oncolytic virotherapy and other biological therapies in translational research. Here we assessed three candidate proteins with the potential to be used as biomarke
Externí odkaz:
https://doaj.org/article/39eaf199de544a3d95e81dd80153bae9
Publikováno v:
Molecular Therapy Oncolytics
Molecular Therapy: Oncolytics, Vol 5, Iss C, Pp 41-61 (2017)
Molecular Therapy: Oncolytics, Vol 5, Iss C, Pp 41-61 (2017)
Oncolytic vaccinia virus (VACV) therapy is an alternative cancer treatment modality that mediates targeted tumor destruction through a tumor-selective replication and an induction of anti-tumor immunity. We developed a humanized tumor mouse model wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1c0b5ffc28e3517400d4b97fe64a48d
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1317
Herein we describe the use of the vaccinia virus strain GLV-1h68 as a theragnostic agent in cancer models. To date, GLV-1h68 has been used successfully in more than 50 xenograft tumor models. The recombinant vaccinia virus strain has been equipped wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::782114b61c616c94cd2b3897645fa04d
https://pubmed.ncbi.nlm.nih.gov/26072410
https://pubmed.ncbi.nlm.nih.gov/26072410
Publikováno v:
Methods in Molecular Biology ISBN: 9781493927265
Herein we describe the use of the vaccinia virus strain GLV-1h68 as a theragnostic agent in cancer models. To date, GLV-1h68 has been used successfully in more than 50 xenograft tumor models. The recombinant vaccinia virus strain has been equipped wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b717798b26af372ccc23984af5ba02cf
https://doi.org/10.1007/978-1-4939-2727-2_13
https://doi.org/10.1007/978-1-4939-2727-2_13
Autor:
Narendiran Rajasekaran, Maysam Pessian, Mehmet O. Kilinc, Ronald Levy, Erik Haefner, Aladar A. Szalay, Nanhai G. Chen, Boris Minev, Audrey Feng, Idit Sagiv Barfi, Ulrike Geissinger, Xing Zhao, Desislava Tsoneva, Kliment Bozhilov, Holbrook E Kohrt
Publikováno v:
Blood. 124:4487-4487
Oncolytic virotherapy is safe and clinically active in solid tumors, however its efficacy in hematologic malignancies as well as in combination with checkpoint inhibitors and radiation is unexplored.To simulate advanced lymphoma, A20 lymphoma cells w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca7989d945988442d951c7226cc48f2a
https://doi.org/10.1182/blood.v124.21.4487.4487
https://doi.org/10.1182/blood.v124.21.4487.4487
Autor:
Desislava Tsoneva, Maysam Pessian, Boris Minev, Qian Zhang, Jason Aguilar, Aladar A. Szalay, Nanhai G. Chen, Mehmet O. Kilinc
Publikováno v:
Journal for Immunotherapy of Cancer
Background Oncolytic viruses are a promising approach for cancer therapy. Recent clinical trials proved the safety and antitumor activity of several oncolytic viruses in solid tumors. However, very little is known about the potential of the oncolytic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7d17034e15212a25e04c25899ca5f4d
http://europepmc.org/articles/PMC3990307
http://europepmc.org/articles/PMC3990307
Autor:
Idit Sagiv-Barfi, Kliment Bozhilov, Xing Zhao, Desislava Tsoneva, Ulrike Geissinger, Audrey Feng, Maysam Pessian, Holbrook E Kohrt, Narendiran Rajesekaran, Mehmet O. Kilinc, Erik Haefner, Boris Minev, Ronald Levy, Aladar A. Szalay, Nanhai G. Chen
Publikováno v:
Journal for Immunotherapy of Cancer
Meeting abstracts Oncolytic virotherapy is safe and clinically active in solid tumors, however its efficacy in hematologic malignancies as well as in combination with checkpoint inhibitors and radiation is unexplored. To simulate advanced lymphoma, A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccd91ccb3520ee1c8fb36fe83e855a9b